Ibrutinib/Lenalidomide/Obinutuzumab/Polatuzumab Vedotin/Prednisone/Venetoclax Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of ibrutinib, lenalidomide, obinutuzumab, polatuzumab vedotin, prednisone, and venetoclax that may potentially be used in the treatment of certain B-cell lymphomas.

**Synonyms:** - Ibrutinib-Lenalidomide-Obinutuzumab-Polatuzumab Vedotin-Prednisone-Venetoclax - Ibrutinib-Lenalidomide-Obinutuzumab-Polatuzumab Vedotin-Prednisone-Venetoclax Regimen - Ibrutinib/Lenalidomide/Obinutuzumab/Polatuzumab Vedotin/Prednisone/Venetoclax - Imbruvica /Revlimid/Gazyva/Polivy/Prednisone/Venclexta - Venetoclax-Ibrutinib-Prednisone-Obinutuzumab-Revlimid Plus Polatuzumab Vedotin - Venetoclax/Ibrutinib/Prednisone/Obinutuzumab/Lenalidomide Plus Polatuzumab Vedotin - Venetoclax/Ibrutinib/Prednisone/Obinutuzumab/Lenalidomide Plus Polatuzumab Vedotin-piiq - Venetoclax/Ibrutinib/Prednisone/Obinutuzumab/Revlimid Plus Polatuzumab Vedotin - ViPOR-P - ViPOR-P - ViPOR-P Regimen